Business
Visionary Holdings Inc. Announces Receipt of Nasdaq Continued Listing Deficiency Letter
TORONTO, April 07, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (Nasdaq: GV) (the “Company”) today announced that it received a notification letter (the “Deficiency Letter”) from the Nasdaq Listing Qualifications Department on April 2, 2026, indicating that the Company is not in compliance with the continued listing requirements set forth in Nasdaq Listing Rule 5250(c)(1). As described in the Deficiency Letter, the Company has not timely filed a Form 6-K containing its interim financial stat
About this update from Visionary Holdings Inc.
[{"type":"text","content":"TORONTO, April 07, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (Nasdaq: GV) (the “Company”) today announced that it received a notification letter (the “Deficiency Letter”) from the Nasdaq Listing Qualifications Department on April 2, 2026, indicating that the Company is not in compliance with the continued listing requirements set forth in Nasdaq Listing Rule 5250(c)(1).","length":379,"tagName":"p"},{"type":"text","content":"As described in the Deficiency Letter, the Company has not timely filed a Form 6-K containing its interim financial statements, including an unaudited balance sheet and income statement as of the end of its second fiscal quarter (the “Required Filing”). As a result, the Company is not currently in compliance with Nasdaq’s periodic reporting requirements for continued listing.","length":378,"tagName":"p"},{"type":"text","content":"In accordance with Nasdaq Listing Rules, the Company has been granted a period of sixty (60) calendar days, or until June 1, 2026, to submit a plan to regain compliance. If Nasdaq accepts the Company’s compliance plan, Nasdaq may grant an exception of up to one hundred eighty (180) calendar days from the original filing due date, or until September 28, 2026, for the Company to regain compliance.","length":398,"tagName":"p"},{"type":"text","content":"The Company intends to submit its compliance plan within the prescribed timeframe and is actively working to complete the Required Filing and any subsequent periodic reports that may become due during the compliance period.","length":223,"tagName":"p"},{"type":"text","content":"The Deficiency Letter has no immediate effect on the listing or trading of the Company’s common shares, which will continue to trade on the Nasdaq Capital Market under the symbol “GV,” subject to the Company’s continued compliance with other listing requirements. However, if the Company fails to submit a compliance plan, if Nasdaq does not accept the plan, or if the Company fails to regain compliance within any extension period granted, Nasdaq may initiate delisting proceedings.In accordance with Nasdaq Listing Rule 5810(b), the Company is required to publicly disclose the receipt of the Deficiency Letter and will submit this press release to Nasdaq’s MarketWatch Department as required. Nasdaq also indicated that the Company will be included on its list of n...